🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Teva Investigational Site 14742
Start Date
2017-10-13
Trial ID
NCT03308968
Treatments Being Tested
The aim of this study is to elucidate whether GLP-1 analogues influence not...
Status
Completed
Location
University Hospital Basel
Start Date
2016-10-17
Trial ID
NCT03141632
Treatments Being Tested
This study plans to learn more about the effect of semaglutide once weekly ...
Status
Completed
Location
University of Colorado Anschutz
Start Date
2022-01-01
Trial ID
NCT04979130
Treatments Being Tested
To determine if a single subcutaneous (SC) administration of TTX at various...
Status
Completed
Location
Celerion
Start Date
2018-02-07
Trial ID
NCT04083833
Treatments Being Tested
This is a Phase III, placebo-controlled, double-blind, randomized study in ...
Status
Completed
Location
Research Site 11420-002
Start Date
2017-11-01
Trial ID
NCT03400800
Treatments Being Tested
The purpose of this study is to measure the effect of LY2189265 to increase...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-02
Trial ID
NCT01300260
This is a 68-week study to evaluate the long-term safety and efficacy of fr...
Status
Terminated
Location
Teva Investigational Site 13834
Start Date
2017-04-27
Trial ID
NCT03107052
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled trial in 2 parts eva...
Status
Withdrawn
Location
Sotuba Malaria Research and Training Center (MRTC)
Start Date
2026-03
Trial ID
NCT07208760
This was a pivotal phase III study designed to evaluate safety, tolerabilit...
Status
Completed
Location
Excel Medical Clinical Trials LLC
Start Date
2021-02-16
Trial ID
NCT04659863
Treatments Being Tested
Glucagon like Peptide -1 (GLP-1) receptor agonists are well known to stimul...
Status
Completed
Location
University Hospital Basel
Start Date
2016-03
Trial ID
NCT02770885
Treatments Being Tested